e-learning
resources
e-learning
Short Videos
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
Login
Search
Short Videos
Time to Breathe
Time to breathe: What respiratory physicians should know about parasomnias
Johan Meurling (London, United Kingdom) & Emer Kelly (Dublin, Ireland)
Short video discussion: Tuesday, 22 October 2022
Open
References:
What respiratory physicians should know about parasomnias. Breathe 2022; 18: 220067
International classification of sleep disorders-third edition. Chest 2014; 146: 1387–1394
NREM sleep parasomnias as disorders of sleep-state dissociation. Nat Rev Neurol 2018; 14: 470–481
Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010; 6: 85–95
NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients. Sleep Med 2019; 53: 181–188
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Vibeke Backer (Copenhagen, Denmark) & Emer Kelly (Dublin, Ireland)
Short video discussion: Tuesday, 4 October 2022
Open
References:
Challenges in the successful management of asthma during conception, pregnancy and delivery. Breathe 2022; 18: 220013
Birth weight and risk of asthma in 3-9-year-old twins: exploring the fetal origins hypothesis. Thorax 2010; 65: 146–149
Fertility treatment among women with asthma: a case-control study of 3689 women with live births. Eur Respir J 2019; 53: 1–8
Family planning, pregnancy and birth in women with lung conditions: a worldwide survey. ERJ open Res 2021; 7: 00357–02021
Asthma in pregnancy. Clin Chest Med 2011; 32: 93–110, ix
ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J 2020; 55: 1901208
Determinants of low risk of asthma exacerbation during pregnancy. Clin Exp Allergy 2018; 48: 23–28
Asthma affects time to pregnancy and fertility: a register-based twin study. Eur Respir J 2014; 43: 1077–85
Fertility outcomes in asthma: a clinical study of 245 women with unexplained infertility. Eur Respir J 2016; 47: 1144–51
Time to breathe: How COVID-19 interacts with interstitial lung disease
Katherine Myall (London, United Kingdom) & Emer Kelly (Dublin, Ireland)
Short video discussion: Monday, 25 April 2022
Open
References:
How COVID-19 interacts with interstitial lung disease. Breathe 2022 18: 210158
Time to breathe: Progress in precision medicine in cystic fibrosis
Peter Barry (Manchester, United Kingdom) & Emer Kelly (Dublin, Ireland)
Short video discussion: Monday, 28 February 2022
Open
References:
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy. Breathe 2021; 17: 210112
Short Video Discussion
Emerging concepts in early COPD
Francesca Polverino (Houston, USA) & Emer Kelly (Dublin, Ireland)
Short video discussion: Monday, 29 August 2022
Open
References:
The low flyers: persistent airflow limitation in young adults. Lancet Respir Med. 2022; S2213-2600: 00250-8
Small airways and early origins of COPD: pathobiological and epidemiological considerations. Eur Respir J 2020; 55: 1902457
Using pulmonary gas exchange to estimate shunt and deadspace in lung disease: Theoretical approach and practical basis
Peter Wagner (San Diego, USA) & Richard Costello (Dublin, Ireland)
Short video discussion: Monday, 18 August 2022
Open
References:
Using pulmonary gas exchange to estimate shunt and deadspace in lung disease: theoretical approach and practical basis. Journal of Applied Physiology 2022; 132: 1104-1113
Sarcoidosis guidelines: How we treat the patient with extrapulmonary manifestations
Robert Baughman (Cincinnati, USA) & Alexander Mathioudakis (Manchester, United Kingdom)
Short video discussion: Tuesday, 24 May 2022
Open
References:
ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021; 58: 2004079
Evolving treatments for chronic cough
Alyn Morice (Cottingham, United Kingdom) & Sheila Ramjug (Altrincham, United Kingdom)
Short video discussion: Monday, 14 February 2022
Open
References:
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136
Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2: 1116-1118
Cough hypersensitivity syndrome: a distinct clinical entity. Lung 2011; 189: 73-79
Hull Airway Reflux Questionnaire. International Society for the Study of Cough
The inhaled allergen challenge test
Zuzana Diamant (Leuven, Belgium) & Emer Kelly (Dublin, Ireland)
Short video discussion: Wednesday, 2 February 2022
Open
References:
Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience. Eur Respir J 2022; 59: 2102782
Provoked models of asthma: what have we learnt? Clin Exp Allergy 2009; 39: 181-92
The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen. Allergy 2005; 60: 56-9
Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol 2013; 132: 1045-1055
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J 2017; 49: 1601526
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J 2018; 52: 1801033
Portable Oxygen Concentrators: Understanding and supporting patient selection
Susan Jacobs (Stanford, USA) & Chris Garvey (San Francisco, USA)
Short video discussion: Friday, 3 September 2021
Open
References:
Portable Oxygen Concentrators (POCs) by Chris Garvey
Management of pleural infection
R. Asciak (Portsmouth, United Kingdom) & N. Rahman (Oxford, United Kingdom)
Short video discussion: Friday, 27 August 2021
Open
References:
European Respiratory Society statement on thoracic ultrasound. Eur Respir J 2021; 57: 2001519
A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019; 54: 1900541
Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection. N Engl J Med 2011; 365: 518-526
Baveno classification, a holistic approach for OSA severity
S. Schiza (Heraklion, Greece) & W. Randerath (Solingen, Germany)
Short video discussion: Monday, 19 July 2021
Open
References:
Sleep-related breathing disturbance, Somnologie 2017; 20 (s2): S97-S180 (GERMAN)
Obstructive sleep apnoea in the general population: highly prevalent but minimal symptoms. Eur Respir J. 2016; 47: 194-202
Challenges and perspectives in obstructive sleep apnoea: Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society. Eur Respir J 2018; 52: 1702616
Management of MDR tuberculosis
Marc Lipman (London, United Kingdom) & Raquel Duarte (Porto, Portugal)
Short video discussion: Thursday, 15 July 2021
Open
Imaging features of COVID-19: What we learned so far
Ádám & Dávid Tárnoki (Budapest, Hungary) & Helmut Prosch (Vienna, Austria)
Short video discussion: Friday, 21 May 2021
Open
References:
CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology 2020; 296: E97-E104
Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021; 57: 2003481
Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics 2020; 40: 1848-1865
Pulmonary fibrosis secondary to COVID-19: a call to arms?. Lancet Respir Med 2020; 8: 750-752
Pericardial effusion in patients with COVID-19: case series. Eur Heart J Case Rep. 2020; 4): 1–7
British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia.
Non-pharmacological management of breathlessness
Karen Heslop-Marshall (Newcastle upon Tyne, United Kingdom) & Beverley Bostock (Moreton in Marsh, United Kingdom)
Short video discussion: Tuesday, 11 May 2021
Open
References:
Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res. 2018; 4: 00094-2018
Asthma and COVID-19
Apostolos Bossios (Stockholm, Sweden) & Stylianos Loukides (Athens, Greece)
Short video discussion: Wednesday, 14 April 2021
Open
References:
Asthma in the Time of COVID-19. Am J Respir Crit Care Med 2021; 203: 785–786
Asthma and COVID-19: Preconceptions about Predisposition. Am J Respir Crit Care Med. 2021; 203: 799–801
Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol 2020; 146: 1295-1301
Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients. Journal of Asthma 2021
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146: 203–206.e3
Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 2020; 146: 1-7
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy 2020; 75: 2764-2774
Pros and Cons of Artificial Intelligence in Respiratory medicine
Konstantinos Kostikas (Ioannina, Greece) & Vitalii Poberezhets (Vinnytsia, Ukraine)
Short video discussion: Wednesday, 7 April 2021
Open
References:
Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature. Eur Respir J 2020; 56: 2000521
Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J 2019; 53: 1801660
Machine Learning and Data Mining Methods in Diabetes Research. Comput Struct Biotechnol J. 2017; 15: 104-116
Latent bias and the implementation of artificial intelligence in medicine. J Am Med Inform Assoc 2020; 27: 2020-2023
End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med 2019; 25: 954-961
The value of nursing staff in apnea patients
Isabel Portela Ferreño (Vigo, Spain) & Andreja Šajnic (Zagreb, Croatia)
Short video discussion: Thursday, 25 March 2021
Open
References:
Adherence to Continuous Positive Airway Pressure Therapy. Proc Am Thorac Soc. 2008; 5: 173–178
CPAP improves social, emotional and sexual scope of obstructive sleep apnea patients and partners. European Respiratory Journal 2020 56: 2142
Novel Aspects of CPAP Treatment and Interventions to Improve CPAP Adherence. J Clin Med 2019; 8: 2220
Pre-habilitation in lung transplant candidates
Tania Janaudis-Ferreira (Montreal, Canada) & Chris Burtin (Diepenbeek, Belgium)
Short video discussion: Wednesday, 10 February 2021
Open
References:
Exercise interventions in solid organ transplant candidates: A systematic review. Clin Transplant 2020; 34: e13900
Changes in 6‐minute walking distance in lung transplant candidates while participating in a home‐based pre‐habilitation program—A retrospective chart review. Clin Transplant 2020; 34: e14045
The effectiveness of prehabilitation or preoperative exercise for surgical patients: a systematic review. JBI Database System Rev Implement Rep 2015; 13: 146-87
Advising colleagues and patients about the COVID-19 vaccine
Mary Horgan & Emer Kelly (Dublin, Ireland)
Short video discussion: Monday, 26 January 2021
Open
Short Video Statements
Cough assistance and secretion management in neuromuscular disease
Tiina Andersen (Bergen, Norway)
Short video discussion: Thursday, 11 February 2021
Open
References:
Airway clearance techniques in neuromuscular disorders: A state of the art review. Respir Med 2018; 136: 98-110
228th ENMC International Workshop: Airway clearance techniques in neuromuscular disorders Naarden, The Netherlands, 3-5 March 2017. Neuromuscul Disord 2018; 28: 289-298
ICU – lung cancer & COVID-19
Anne-Claire Toffart (Grenoble, France)
Short video statement: Monday, 21 December 2020
Open
References:
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis, ESMO Open. 2020; 5: e000947
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19), Eur J Cancer 2020; 141: 62-81
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, Lancet Oncol 2020; 21: 914–22
COVID-19 in patients with lung cancer, Ann Oncol 2020; 10:1386-1396
Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis
Francesco Bonella (Essen, Germany)
Short video statement: Wednesday, 2 December 2020
Open
References:
Pulmonary alveolar proteinosis, Nature Reviews Disease Primers 2019; 5: 16
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis, N Engl J Med 2019; 381:923-932
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis, N Engl J Med 2020; 383:1635-1644
Screening for lung cancer - Opportunities and challenges
Georgia Hardavella (Athens, Greece)
Short video statement: Monday, 26 October 2020
Open
References:
ESR/ERS statement paper on lung cancer srcreening
ESR/ERS white paper on lung cancer screening
European position statement on lung cancer screening
Biologics for eosinophilic granulomatosis with polyangiitis
Andrew Menzies-Gow (London, United Kingdom)
Short video statement: Thursday, 22 October 2020
Open
References:
Mepolizumab or placebo for Eosinophilic Granulomatosis with Polynagiitis
Rituximab as induction therapy in EGPA refractory to conventional immunosuppressive treatment: A 36 month follow up analysis
Triple therapy in COPD: Oportunities and challenges
Marc Miravitlles (Barcelona, Spain)
Short video statement: Wednesday, 16 September 2020
Open
References:
Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
COVID-19
Telemedicine and e-medicine during a pandemic
Konstantinos Kostikas (Ioannina, Greece)
COVID-19 video statement: Monday, 31 August 2020
Open
Symptom palliation in COVID-19
Anita Simonds (London, United Kingdom)
COVID-19 video statement: Tuesday, 16 June 2020
Open
Lung function testing in the COVID era: safety concerns you should consider
Frans de Jongh (Amsterdam, Netherlands)
COVID-19 video statement: Monday, 09 June 2020
Open
How to manage patients with mild disease in the primary care?
Hilary Pinnock (Edinburgh, United Kingdom)
COVID-19 video statement: Monday, 08 June 2020
Open
COVID-19 infection and smoking: Myths and reality
Paraskevi Katsaounou (Athens, Greece)
COVID-19 video statement: Wednesday, 03 June 2020
Open
The role of physiotherapists in the front line fighting against COVID-19
Rachael Moses (Preston, United Kingdom)
COVID-19 video statement: Thursday, 28 May 2020
Open
Ventilatory support on patients with acute respiratory failure with COVID-19
Davide Chiumello (Milan, Italy)
COVID-19 video statement: Wednesday, 27 May 2020
Open
COVID-19 infection in children: Myths and reality
Fabio Midulla (Rome, Italy)
COVID-19 video statement: Friday, 15 May 2020
Open
Post-COVID rehabilitation and management strategies, including post hospital discharge and the role of the respiratory physiotherapist
Ioannis Vogiatzis (Newcastle upon Tyne, United Kingdom)
COVID-19 video statement: Thursday, 14 May 2020
Open
How to manage patients after the ICU
Stefano Nava (Bologna, Italy)
COVID-19 video statement: Wednesday, 13 May 2020
Open
Organisation of healthcare systems
Marc Humbert (Paris, France)
COVID-19 video statement: Tuesday, 12 May 2020
Open
Testimonial from a doctor fighting COVID-19
Stefano Nava (Bologna, Italy)
COVID-19 video statement: Monday, 11 May 2020
Open
ILDs and COVID-19
Katerina Antoniou (Heraklion, Greece)
COVID-19 video statement: Friday, 8 May 2020
Open
How to manage patients with arterial hypertension in the era of COVID-19
Kostas Tsioufis (Athens, Greece)
COVID-19 video statement: Tuesday, 17 April 2020
Open
Introduction
Stylianos Loukides (Athens, Greece)
COVID-19 video statement: Tuesday, 07 April 2020
Open
Management of respiratory diseases in the COVID-19 pandemic
Konstantinos Kostikas (Ioannina, Greece)
COVID-19 video statement: Tuesday, 07 April 2020
Open
Indications of NIV use for COVID-infected patients
Sofia Schiza (Heraklion, Greece)
COVID-19 video statement: Tuesday, 08 April 2020
Open
In hospital management
Petros Bakakos (Athens, Greece)
COVID-19 video statement: Tuesday, 08 April 2020
Open
Therapeutic management - Current status and future developments
Argyris Tzouvelekis (Athens, Greece)
COVID-19 video statement: Tuesday, 08 April 2020
Open
ICU management
Antonia Koutsoukou (Athens, Greece)
COVID-19 video statement: Tuesday, 08 April 2020
Open
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept